During the intraday session, the stock reached an all-time high, jumping 9.26 per cent to Rs 1,989 on the NSE.

The company's foray into electrolyte manufacturing complements the government's Make in India initiative.

Pharma Intermediates took the lead, contributing 84.0 per cent, followed by Specialty Chemicals at 16.0 per cent. 

An ace investor, Ashish Kacholia holds 2.13 per cent stake in in the company, aggregating to Rs 83.71 crore.

The pharmaceutical sector in India ranks third in terms of volume and fourteenth in terms of value (both globally).  The domestic market is anticipated to increase three times in the next ten years, according to the Indian Economic Survey 2021.

BSE Smallcap index slipped 0.58 per cent to close the session at 28,611.92.